Getting your player ready...
TRENTON, N.J. — An experimental menopause treatment drugmaker Wyeth is developing reduced hot flashes, sleeping troubles and other symptoms and did not increase breast tenderness, a problem that bothers many women taking menopause drugs, according to data from two studies.
Wyeth, long a dominant player in menopause treatments, is developing a compound called Aprela that combines the hormone estrogen with bazedoxifene, part of a class of drugs called selective estrogen receptor modulators.
